Goldman Sachs’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-25,189
Closed -$284K 6027
2024
Q2
$284K Hold
25,189
﹤0.01% 5130
2024
Q1
$280K Buy
+25,189
New +$278K ﹤0.01% 5004
2023
Q3
Sell
-27,367
Closed -$292K 5807
2023
Q2
$292K Hold
27,367
﹤0.01% 5021
2023
Q1
$287K Hold
27,367
﹤0.01% 5132
2022
Q4
$281K Buy
+27,367
New +$278K ﹤0.01% 5171

Other funds holding RENE

Goldman Sachs's RENE Position: Q3 2024 in Review

Goldman Sachs sold out of Cartesian Growth Corp II (RENE) in Q3 2024, closing a stake of 25,189 shares — an estimated $284K sold.

Goldman Sachs first reported a position in RENE in Q4 2022 and held it in 5 quarters. The position peaked at $292K in Q2 2023. 32 funds tracked by Wall St. Rank hold RENE as of Q3 2024.

  • Goldman Sachs reported no remaining Cartesian Growth Corp II position as of Q3 2024 after selling out during the quarter.
  • Goldman Sachs sold 25,189 Cartesian Growth Corp II shares in Q3 2024, an estimated $284K.
  • Goldman Sachs first reported a position in Cartesian Growth Corp II in Q4 2022 and held it in 5 quarters.
  • Goldman Sachs's Cartesian Growth Corp II position peaked at $292K in Q2 2023.
  • 32 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q3 2024.

Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.